Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival
Keyword(s):
2007 ◽
Vol 39
(2)
◽
pp. 493-498
◽
Keyword(s):
2016 ◽
Vol 139
(1)
◽
pp. 194-204
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):